Annual D&A
$5.75B$679.27M+13.41%
Summary
- Current Value
- As of today, AZN annual D&A is $5.75B, up +13.41% on
- Historical Performance
- AZN annual D&A is up +9.37% over the past 3 years, up +98.43% over the past 5 years
- All-Time High Comparison
- AZN annual D&A is currently at its all-time high
- 3-Year Low Comparison
- AZN annual D&A is +16.47% above its 3-year low of $4.93B reached on
- Sector Comparison
- AZN annual D&A is higher than 100.00% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $5.75B | +13.4% | +9.4% | +98.4% | +204.3% | |
| Quarterly D&A | $1.51B | +111.4% | +20.4% | +177.4% | +220.5% | |
| TTM D&A | $5.75B | +13.4% | +9.4% | +98.4% | +204.3% | |
| Price | $205.55 | +176.1% | +194.9% | +297.7% | +748.1% | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $48.63B | +3.3% | +18.4% | +99.3% | +92.6% | |
| Annual Operating Expenses | $30.14B | +8.5% | +30.8% | +91.5% | +117.9% | |
| Annual Revenue | $58.88B | +8.8% | +32.8% | +113.4% | +76.7% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.75B | at high | |
| 5Y | $5.75B | at high | |
| All | $5.75B | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.93B | +16.5% | |
| 5Y | $2.90B | N/A | +98.4% |
| All | $258.25M | +2125.2% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of AZN?
As of today, AZN annual D&A is $5.75B
What is 1-year change in AZN annual D&A?
AZN annual D&A is up +13.41% year-over-year
What is 3-year change in AZN annual D&A?
AZN annual D&A is up +9.37% over the past 3 years
How far is AZN annual D&A from its all-time high?
AZN annual D&A is currently at its all-time high
How does AZN annual D&A rank versus sector peers?
AZN annual D&A is higher than 100.00% of companies in Healthcare sector
When is AZN next annual earnings release?
As of today, the next annual earnings release for AZN has not been scheduled
Quarterly D&A
$1.51B$32.04M-2.08%
Summary
- Current Value
- As of today, AZN quarterly D&A is $1.51B, down -2.08% on
- Historical Performance
- AZN quarterly D&A is up +111.37% year-over-year, up +20.35% over the past 3 years
- All-Time High Comparison
- AZN quarterly D&A is currently -45.87% below its historical high of $2.79B set on
- 3-Year Low Comparison
- AZN quarterly D&A is +111.37% above its 3-year low of $714.00M reached on
- Sector Comparison
- AZN quarterly D&A is higher than 99.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $1.51B | -2.1% | +111.4% | +20.4% | +177.4% | |
| Annual D&A | $5.75B | – | +13.4% | +9.4% | +98.4% | |
| TTM D&A | $5.75B | +16.1% | +13.4% | +9.4% | +98.4% | |
| Price | $205.55 | +132.0% | +176.1% | +194.9% | +297.7% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Total Expenses | $13.16B | +4.6% | -0.8% | +27.7% | +90.5% | |
| Quarterly Operating Expenses | $8.25B | +8.4% | +3.4% | +36.1% | +83.2% | |
| Quarterly Revenue | $15.48B | +2.5% | +4.9% | +38.1% | +95.5% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.54B | -2.1% | |
| 3Y | $1.82B | -16.9% | |
| 5Y | $2.79B | -45.9% | |
| All | $2.79B | -45.9% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $714.00M | N/A | +111.4% |
| 3Y | $714.00M | +111.4% | |
| 5Y | -$236.00M | +739.5% | |
| All | -$236.00M | +739.5% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of AZN?
As of today, AZN quarterly D&A is $1.51B
What is AZN quarterly D&A most recent change?
AZN quarterly D&A was down -2.08% on December 31, 2025
What is 1-year change in AZN quarterly D&A?
AZN quarterly D&A is up +111.37% year-over-year
How far is AZN quarterly D&A from its all-time high?
AZN quarterly D&A is currently -45.87% below its historical high of $2.79B set on September 30, 2021
How does AZN quarterly D&A rank versus sector peers?
AZN quarterly D&A is higher than 99.90% of companies in Healthcare sector
When is AZN next earnings release?
The next earnings release for AZN is on
TTM D&A
$5.75B$795.19M+16.06%
Summary
- Current Value
- As of today, AZN TTM D&A is $5.75B, up +16.06% on
- Historical Performance
- AZN TTM D&A is up +13.45% year-over-year, up +9.37% over the past 3 years
- All-Time High Comparison
- AZN TTM D&A is currently at its all-time high
- 3-Year Low Comparison
- AZN TTM D&A is +22.60% above its 3-year low of $4.69B reached on
- Sector Comparison
- AZN TTM D&A is higher than 100.00% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $5.75B | +16.1% | +13.4% | +9.4% | +98.4% | |
| Annual D&A | $5.75B | – | +13.4% | +9.4% | +98.4% | |
| Quarterly D&A | $1.51B | -2.1% | +111.4% | +20.4% | +177.4% | |
| Price | $205.55 | +132.0% | +176.1% | +194.9% | +297.7% | |
| TTM SG&A | $29.57B | +5097.6% | +5241.1% | +5417.2% | +7311.5% | |
| TTM Revenue | $58.80B | +1.3% | +9.0% | +32.6% | +112.3% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.75B | at high | |
| 3Y | $5.75B | at high | |
| 5Y | $5.75B | at high | |
| All | $5.75B | at high |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.95B | +16.1% | |
| 3Y | $4.69B | +22.6% | |
| 5Y | $2.85B | +101.5% | |
| All | $260.66M | +2104.5% |
TTM D&A History
FAQ
What is the current TTM D&A of AZN?
As of today, AZN TTM D&A is $5.75B
What is AZN TTM D&A most recent change?
AZN TTM D&A was up +16.06% on December 31, 2025
What is 1-year change in AZN TTM D&A?
AZN TTM D&A is up +13.45% year-over-year
How far is AZN TTM D&A from its all-time high?
AZN TTM D&A is currently at its all-time high
How does AZN TTM D&A rank versus sector peers?
AZN TTM D&A is higher than 100.00% of companies in Healthcare sector
When is AZN next earnings release?
The next earnings release for AZN is on
Data Sources & References
- AZN Official Website www.astrazeneca.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/901832/000165495426001073/0001654954-26-001073-index.htm
- AZN Profile on Yahoo Finance finance.yahoo.com/quote/AZN
- AZN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/azn